Stockscreener 앱 받기
1.9601
7.98%
-0.1699
시장 영업 전:
2.00
0.0399
+2.04%
전일 마감가:
$2.13
열려 있는:
$2.13
하루 거래량:
58,715
Relative Volume:
0.98
시가총액:
$8.16M
수익:
-
순이익/손실:
$-33.44M
주가수익비율:
-0.1223
EPS:
-16.0242
순현금흐름:
$-28.30M
1주 성능:
-10.50%
1개월 성능:
-6.22%
6개월 성능:
-31.70%
1년 성능:
-98.92%
1일 변동 폭
$1.95
$2.22
1주일 범위
$1.95
$2.22
52주 변동 폭
$1.95
$268.00
Nucana Plc Adr Stock (NCNA) Company Profile
Compare NCNA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NCNA
Nucana Plc Adr
|
1.9601 | 8.86M | 0 | -33.44M | -28.30M | -16.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Nucana Plc Adr Stock (NCNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-30 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-03-03 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-10-22 | 개시 | Truist | Buy |
| 2020-07-24 | 개시 | Oppenheimer | Outperform |
| 2019-08-19 | 개시 | H.C. Wainwright | Buy |
| 2018-10-19 | 개시 | Piper Jaffray | Overweight |
| 2017-10-23 | 개시 | Citigroup | Buy |
| 2017-10-23 | 개시 | Jefferies | Buy |
| 2017-10-23 | 개시 | William Blair | Outperform |
모두보기
Nucana Plc Adr 주식(NCNA)의 최신 뉴스
Persistent bearish signals and technical resistance — NuCana stock drops 4.63% - Traders Union
NuCana sees a dip — What is pressuring the stock - Traders Union
NCNA Earnings History & Surprises | EPS & Revenue Results | NUCANA PLC-ADR (NASDAQ:NCNA) - ChartMill
NuCana stock price forecast: Bear signals weigh as NCNA dips beneath key levels - Traders Union
NCNA Fundamental Analysis | NUCANA PLC-ADR (NASDAQ:NCNA) - ChartMill
Weak technical signals and persistent selling — NuCana stock falls 4.02% - Traders Union
What is behind NuCana recent drop in value today - Traders Union
What triggered NuCana latest price surge - Traders Union
NuCana stock: persistent negative momentum drives 3.40% gain despite mixed technicals - Traders Union
NuCana climbs today: Key reasons behind the rally - Traders Union
Buying pressure lifts NuCana higher in today trading - Traders Union
NuCana slides today: Key reasons behind the decline - Traders Union
NuCana stock price forecast: Further downside risk as NCNA drops 3.75% near support levels - Traders Union
NuCana stock: Bearish trends and weak support drive continued price decline - Traders Union
Deeply oversold RSI and bearish technicals — NuCana stock gains 3% - Traders Union
-5.76% for NuCana stock — oversold levels signal persistent bearish pressure - Traders Union
-5.45% for NuCana stock — technical signals warn of limited upside potential - Traders Union
Here’s why NuCana is sliding (January 26) - Traders Union
NuCana is falling today: what traders are watching (January 9) - Traders Union
NuCana stock price forecast: Sellers remain in control as NCNA edges toward support - Traders Union
NuCana stock drops 2.16% as sellers dominate below key moving averages - Traders Union
NuCana stock price forecast: rangebound days expected as NCNA holds steady near resistance - Traders Union
NuCana Appoints Theresa Bruce as Chief Operating Officer - GlobeNewswire Inc.
NuCana appoints Theresa Bruce as chief operating officer - Investing.com
NuCana (NASDAQ:NCNA) Trading Up 1.6% – Here’s Why - Defense World
NuCana plc ADR (NCNA) Stock Price Prediction for 2026, 2030-2040 - Traders Union
NuCana plc ADR (NCNA) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union
NuCana reports partial responses in melanoma treatment trial - Investing.com
NuCana stock rises after securing key patent in China for cancer drug - Investing.com
Taking the lead: NuCana plc ADR (NCNA) - Setenews
NuCana compliant with all Nasdaq continued listing criteria - MSN
Rising Momentum in European ADRs: A Strategic Entry Point for US Investors - AInvest
NuCana regains Nasdaq compliance, extends cash runway into 2029 - Investing.com
Wall Street Today: Dow, Nasdaq, S&P 500 open flat as investors focus on China tariff deadline; Nvidia down 1.3% - Mint
NuCana plc Announces Change in American Depository Shares Ratio to Enhance Liquidity and Nasdaq Compliance - Quiver Quantitative
NuCana Cancels Series A Warrants Post-ATM Execution - The Globe and Mail
NuCana completes cancellation of all remaining Series A Warrants - Investing.com
NuCana Announces ADS Ratio Change to Enhance Liquidity - The Globe and Mail
NuCana to implement 1:200 reverse ADS split to boost share price - Investing.com
NuCana (NCNA) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
NCNA Gets Second Nasdaq Notice; Hearing to Delay Potential Delisting - Stock Titan
NuCana enters $100 million at-the-market sales agreement for ADS offering - Investing.com
NuCana CEO takes leave of absence due to health reasons - Investing.com
nucana plc announces annual report release and upcoming agm - Investing.com
NuCana's Melanoma Breakthrough: Key Drug Advances to Expansion Trial, Q1 Losses Drop 63% Year-over-Year - Stock Titan
NuCana prices $7 million direct offering of ADSs and warrants - Investing.com
Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season? - Zacks Investment Research
RLYB Ends Pregnancy-Related Rare Disease Program, Stock Tanks - Yahoo Finance
NuCana secures new US patent for cancer treatment NUC-7738 - Investing.com
NuCana Stock Soars 151% on Upbeat Efficacy Data From Melanoma Study - Yahoo Finance
NCNANuCana plc ADR Earnings - Finviz
Nucana Plc Adr (NCNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.69%
0.68%
자본화:
|
볼륨(24시간):